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ABSTRACT
Objectives. The aims of our study were 
to investigate the prevalence of ultra-
sound (US) pathological abnormalities 
in the hip of psoriatic arthritis (PsA) 
patients and compare them with the 
clinical findings.
Methods. Sixty-five PsA patients were 
enrolled in the study. Bilateral examina-
tion of the hip was performed to detect 
joint effusion, synovial hypertrophy, 
irregularity of femoral head and neck 
profile as seen in erosions and/or osteo-
phytes.
Results. Joint effusion was detected 
in 20 out of 130 hips (15%). Synovial 
hypertrophy was present in 12 out of 
20 hips (60%) associated with effusion 
(9.3% of all hip joints) and only 1 of 
them showed PD signal. Small effusion 
without synovial proliferation was im-
aged in 8 out of 20 hips (40%). On the 
whole 14 out of 65 patients (21%) had 
joint effusion with or without synovial 
hypertrophy using US. No erosions of 
the femoral head and neck profile were 
detected whilst osteophytes were im-
aged in 27 joints (20%). No US abnor-
malities were demonstrated in 18 hips 
with pain/tenderness on physical exam-
ination, whilst joint effusion was seen 
in 8 joints which were asymptomatic.
Conclusions. US is a useful imaging 
method to evaluate hip involvement in 
PsA that could be integrated into rou-
tine PsA management even if patients 
do not complain of hip involvement.
Introduction
Psoriatic arthritis (PsA) is a chronic 
inflammatory joint disease associated 
with psoriasis and classified among 
the spondyloarthropathies, a family of 
related disorders linked by common 
genetics (HLA-B27) and common pa-
thology (enthesitis) (1). Ankylosing 
spondylitis (AS) is the prototype of 
the spondyloarthropathies and hip in-
volvement is one of the features and 
a major marker for disease severity 
(2). However, little is known about the 
prevalence and the outcome of hip joint 
involvement in PsA (3). 
Ultrasound (US) is a useful technique 
for the examination of joint disorders 
to detect joint effusion, synovitis, ten-
don pathology and to image bone ero-
sion with greater sensitivity than stand-
ard x-ray (4-7). It is being increasingly 
used in rheumatological practice and it 
is frequently employed in the routine 
examination of hips (8). 
However, to the best of our knowledge, 
no study has reported data on the prev-
alence and the features of hip arthropa-
thy in PsA evaluated by US.
The aims of our study were to investi-
gate the prevalence of US detected ab-
normalities in the hips of PsA patients 
and to compare them with the clinical 
findings.
Patients and methods 
This multi-centre study involved 4 Ital-
ian Rheumatology Units (Rheumatolo-
gy Unit of University of Pisa, Università 
Politecnica delle Marche, University 
of Pavia, the Sapienza University of 
Rome) and the Rheumatology Depart-
ment of Antrim Hospital, Northern Ire-
land, UK. US examinations, including 
grey-scale and power Doppler exami-
nations, were carried out using a Logiq 
9 machine (General Electrics Medical 
Systems, Milwaukee, WI) with a linear 
probe operating at 9 MHz by a rheuma-
tologist who was well experienced in 
musculoskeletal US and blind to both 
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the clinical and laboratory data of the 
patients. Before the start of the study, 
all the sonographers reached an agree-
ment on both the scanning technique 
and the definition of the pathological 
findings of interest. The study was per-
formed according to the Declaration of 
Helsinki and local regulations and in-
formed consent was obtained from all 
patients. 
Patients
Sixty-five PsA patients attending the 
out-patient and the in-patient clinics of 
the Rheumatology Units involved were 
consecutively enrolled in the study. 
PsA was diagnosed according to the 
CASPAR criteria (9). In accordance 
with Moll and Wright subtypes, 53 pa-
tients showed peripheral joint involve-
ment (28 oligoarticular ad 25 polyartic-
ular), 12 axial involvement (in 2 patients 
axial and peripheral involvement were 
associated) (10). Thirty-five patients 
were treated with DMARDs (24 with 
methotrexate, 4 with sulphasalazine, 2 
with sulphasalazine plus cyclosporine 
A and 3 with leflunomide), 23 with anti-
TNF-alpha inhibitors (in 12 associated 
to DMARDs), 20 were taking steroids 
and 22 non-steroidal anti-inflammatory 
drugs. Patients who had a diagnosis of 
hip dysplasia or had been subjected to 
surgical treatment of the hip or received 
corticosteroid or hyaluronic acid injec-
tion into the hip, within the previous 3 
months, were excluded. Demographic 
and clinical characteristics of the study 
patients are reported in Table I.
Clinical assessment
Prior to US assessment all patients were 
evaluated by a rheumatologist (not in-
volved in US examination) for the pres-
ence/absence of pain, tenderness and 
joint mobility, according to standard 
techniques (11). 
The patients were also assessed for 
history of hip pain and laboratory test 
abnormalities (elevation of ESR and C-
reactive protein, presence or absence of 
rheumatoid factor and antibodies to anti 
citrullinated peptides). Current medical 
therapies were recorded and the BAS-
DAI and BASFI questionnaires were 
completed for every patient. 
In total 130 hip joints of 65 patients 
were studied.
 
US scanning technique
According to EULAR guidelines for 
musculoskeletal US in rheumatology, 
bilateral examination of the hip was 
performed with the patient supine and 
the hip in neutral position (12). Ob-
lique longitudinal plane over the femo-
ral neck to examine the anterior syno-
vial recess, using the femoral head as 
a landmark, and transverse scan were 
adopted to detect joint effusion, syno-
vial hypertrophy, irregularity of the 
femoral head and neck profile for ero-
sions and/or osteophytes. When syno-
vial hypertrophy was detected, power 
Doppler examination was performed 
and the following settings used: PRF 
500 Hz, Doppler frequency 7.5 MHz 
and Doppler gain to avoid random 
noise visualisation. 
US image interpretation
Joint effusion, synovial hypertrophy 
and bone erosion of the femur and/or 
acetabulum were defined according to 
the Outcome Measures in Rheumatoid 
Arthritis Clinical Trials (OMERACT) 
definitions (13). The limit for normal 
hip dimension was defined according to 
Koski et al. with values of ≥7 millime-
tre and a difference between hips of 1 or 
more millimetres was considered sug-
gestive of intracapsular effusion (14). 
Statistical analysis 
Descriptive results are reported as mean 
and standard deviation (SD) according 
to their distribution. The student t-test 
was chosen to compare quantitative 
parameters in large samples of similar 
variance. Categorical variables were 
analysed using chi-squared tests. The 
findings were expressed as mean and 
standard deviation from the mean. Val-
ues of p<0.05 were considered to be 
statistically significant.
Results
Using US, joint effusion was detected 
in 20 out of 130 hips (15%). Synovial 
hypertrophy was present in 12 out of 
20 hips (60%) associated with effu-
sion (9.3% of all hips) and only 1 out of 
them showed PD signal. Small effusion 
without synovial hypertrophy was im-
aged in 8 out of 20 hips (40%). On the 
whole, 14 out of 65 patients (21%) had 
joint effusion with or without synovial 
proliferation (in 6 patients joint effusion 
was bilateral and in 8 unilateral) (Fig. 
1). No erosions of the femoral head and 
neck profile were detected in any joint, 
whilst osteophytes were imaged in 27 
joints (20%). We observed a difference 
in disease duration (140 vs. 95 months) 
and in BASDAI score (7.75 vs. 4.8) be-
tween patients who showed osteophytes 
and patients with no osteophytes at US 
examination. Such a difference was not 
statistically significant. 
Joint effusion was imaged in 8 hips 
which were asymptomatic, whilst no 
US abnormalities were detected in 18 
joints which were painful upon clinical 
examination. 
Patients with US-detected hip involve-
ment did not differ significantly in 
terms of gender, age, disease duration, 
BASDAI and BASFI scores from pa-
tients with normal US findings. ESR 
and CRP were higher in the group with 
hip synovitis. 
When we considered PsA subtypes, we 
observed hip involvement in 6 patients 
with polyarticular arthritis (one of 
such patients had axial and peripheral 
involvement), in 7 with oligoarticular 
arthritis, in 1 with psoriatic spondylitis 
alone. No statistical difference was ob-
served in the prevalence of hip involve-
ment in the different PsA subtypes. 
At the time of the US examination, 22 
(34%) patients complained of hip pain 
Table I. Main characteristics of patients with psoriatic arthritis.
Number of M/F Age (years) mean±SD Disease duration (months)
patients   (range) mean±SD (range)
65  37/28 53 ± 12.83 years 106 ± 101 months
   (87–16) (528–7)
M/F: male/female ratio; SD: standard deviation.
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and/or physical examination elicited 
tenderness (for a total of 30 joints). Hip 
pain and/or tenderness were reported 
by 30 (46%) subjects (for a total of 47 
joints). 
The pathological findings detected by 
US examination are reported in Table II.
Table III illustrates the relationship 
between US and clinical findings in-
dicative of hip joint inflammation. The 
agreement between clinical and US 
findings was indeed low, with non-sig-
nificant concordance on positive or neg-
ative findings.
Discussion
Although spondyloarthropathies have 
different symptoms and outcomes, sim-
ilar clinical features are common to AS, 
PsA, reactive arthritis, spondyloarthri-
tis associated with inflammatory bowel 
disease and undifferentiated spondy-
loarthritis. Indeed, inflammatory back 
pain due to sacroiliitis, inflammation 
at other locations in the axial skeleton, 
enthesitis and peripheral arthritis are 
common manifestations of the disor-
ders in this spectrum (15).
Hip involvement is a common and 
disabling problem in AS patients and it 
often carries a more severe prognosis. 
A very recent study of 56 patients af-
fected by AS reported that one third of 
patients complained of symptoms that 
were compatible with joint inflamma-
tion and US abnormalities were dem-
onstrated in a similar proportion of 
subjects (16). The prevalence of hip 
involvement in PsA has been the topic 
of very few investigations. To the best 
of our knowledge, only one study of 
hip involvement in PsA is reported in 
the international literature (3). Michet 
et al. performed a prospective analy-
sis of PsA hip disease in a cohort of 
504 patients evaluated by subsequent 
clinic visits and chart and radiographic 
review. The Authors concluded that ar-
thropathy occurs infrequently in PsA 
i.e. only in <7% of patients followed 
up for a median of 5 years.
Plain radiographs have traditionally 
been used to detect and estimate the 
extent of joint damage. However, it is 
well known that US imaging can lead 
to earlier detection of joint damage than 
plain radiographs and is also a sensitive 
means of assessing inflammation (17). 
The availability of sensitive and accu-
rate tools for evaluating disease sever-
ity is fundamental to enable appropriate 
treatment planning in PsA.
Using US, we imaged 130 hips of PsA 
patients and identified joint effusion 
with or without synovial proliferation 
in 14 out of 65 patients (21%), lower 
than that reported in AS (21% vs. 
37.5%) (16). It is interesting to observe 
the different results provided by clini-
cal examination and US assessment. 
No US abnormalities were detected in 
18 hips with pain/tenderness at physical 
examination whilst joint effusion was 
imaged in 8 joints which were entirely 
asymptomatic. Given the sensitivity 
and the specificity of the two studies 
previously published for other joints (7, 
18), we speculate that clinical examina-
tion is non-specific and is affected by 
Fig. 1. Proliferative synovitis of the hip. Longitudinal anterior view shows marked joint cavity widen-
ing (distance between femoral neck and ileopsoas fascia equal to 11.1 mm) with evident sign of syno-
vial proliferation (*). Intra-articular abnormal amount of synovial fluid enhances the chondro-synovial 
margin visualisation where ultrasound beam direction is perpendicular to the femoral cartilage surface. 
a: acetabulum; f: femur.
Table II. Pathological findings detected by US examination of  the hip in psoriatic arthritis 
patients
 US findings Involved hip n. (%) Patients n. (%)
 Joint effusion 20/130 (15%) 14/65 (21%)
 Synovial hypertrophy 12/20 (60%) 7/65 (10%)
 Intra-articular power Doppler 1/130 (0.7%) 1/65 (1.5%)
 Bone erosions 0/130 (0%) 0/65 (0%)
Table III. Relationship between US and clinical findings indicative of hip joint inflam- 
mation.
 
  Clinical findings 
US findings  Presence Absence Total 
Hip joint inflammation Presence 12 8 20
 Absence 18 102 110
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several confounders, mostly the pres-
ence of osteoarthritis, but also tendon 
and periarticular involvement (better 
visualised by US). 
In our study, intra-articular PD signal 
was found in only 1 out of 130 joints 
which is low. We have seen similar re-
sults in previous studies looking at knee 
involvement in PsA and RA patients, 
since the greater the interface between 
the probe and the joint, the less chance 
there is of detecting PD signal (7, 18).
No erosions were detected in any hip 
joint evaluated. Again this data re-
calls the observations obtained by US 
examinations of the knee in PsA and 
RA patients. As for the knee, the ana-
tomical conformation of the hip is such 
that the US beam cannot reach a large 
portion of femur and acetabulum pro-
file because of their position inside the 
joint and the thickness of subcutaneous 
tissue and muscle mass. It is possible 
to see only a limited portion of articu-
lar bone and this can undoubtedly lead 
to bone erosions being missed in cer-
tain ‘hidden’ regions of the joint (8). It 
would be interesting to evaluate the hip 
joint in PsA patients by MRI and CT 
scans in order to clarify the prevalence 
of erosions in PsA. 
In our study osteophytes were imaged 
in 27 joints (20%). An associated os-
teoarthritis could partially explain the 
frequency of osteophytes we found. 
However, when we compare the fea-
tures of patients who had osteophytes 
with patients with no osteophytes at US 
examination, no statistically significant 
differences were found in mean age, 
disease duration and in BASDAI score, 
even if a trend to significance was giv-
en for the latter. 
We can hypothesise that damage of ar-
ticular structures due to inflammation 
or abnormal posture (for instance, for 
axial or lower limb involvement) might 
favour the appearance of secondary os-
teoarthritis of the hip in PsA patients. 
Our study is preliminary and has some 
limitations. We focused our attention 
on the prevalence of effusion and syno-
vial hypertrophy but no data on signs 
of enthesitis are reported. Moreover, it 
would be interesting to evaluate pos-
sible differences in hip involvement in 
PsA subtypes, i.e. evaluate the frequen-
cy of hip arthropathy in the axial type. 
Unfortunately, the limited number of 
patients enrolled and the small number 
of patients with axial involvement (only 
12) does not allow such an analysis. 
In conclusion, US is a useful imaging 
method to evaluate hip involvement in 
PsA which could be integrated into rou-
tine PsA management even if patients 
do not complain of hip symptoms. US 
should be used in patients complaining 
of hip pain, to properly distinguish PsA 
activity from the osteoarthritis thereby 
determining more appropriate treat-
ment. 
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